Technical Analysis for THMO - ThermoGenesis Holdings, Inc.

Grade Last Price % Change Price Change
F 2.7 4.25% 0.11
THMO closed up 7.02 percent on Wednesday, April 21, 2021, on 49 percent of normal volume.
Earnings due: May 12
*** please verify all earnings dates ***

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Up
Historical THMO trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 4.25%
Pocket Pivot Bullish Swing Setup 4.25%
Lower Bollinger Band Touch Weakness 4.25%
Oversold Stochastic Weakness 4.25%
Lower Bollinger Band Walk Weakness 11.57%
BB Squeeze Ended Range Expansion 11.57%
Lower Bollinger Band Touch Weakness 11.57%
Oversold Stochastic Weakness 11.57%
Bollinger Band Squeeze Range Contraction 10.66%
Stochastic Reached Oversold Weakness 10.66%
Older End-of-Day Signals for THMO ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible Pocket Pivot about 2 hours ago
Up 5% about 5 hours ago
60 Minute Opening Range Breakout about 5 hours ago
Up 3% about 5 hours ago
Rose Above 20 DMA about 5 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


ThermoGenesis Holdings, Inc. Description

ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for chimeric antigen receptor (CAR)-T and other cell-based therapies in the United States, China, Rest of Asia, Europe, and internationally. It markets a suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally closed CAR-TXpress platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. The company operates through two segments, Device and Clinical Development. It manufactures and markets products for clinical bio-banking applications, including AXP Automated Cell Separation System, an automated cell separation system for isolating and retrieving stem and progenitor cells from umbilical cord blood; and BioArchive Automated Cryopreservation System, an automated, robotic, liquid nitrogen controlled-rate-freezing, and cryogenic storage system for cord blood samples and cell therapeutic products used in clinical applications. The company also offers PXP Point-of-Care System, an automated sterile system that allows for the automated processing of autologous peripheral blood or bone marrow aspirate derived stem cells at the point-of-care, such as surgical centers or clinics; and X-Series products, such as X-Lab for cell isolation, X-Wash System for cell washing and reformulation, X-Mini for small scale cell purification, and X-BACS System under development for large scale cell purification using the company's proprietary buoyance-activated cell sorting (BACS) technology, as well as CAR-TXpress platform. The company sells its products through independent distributors and directly to end-user. The company was formerly known as Cesca Therapeutics Inc. and changed its name to ThermoGenesis Holdings, Inc. in November 2019. ThermoGenesis Holdings, Inc. was founded in 1986 and is headquartered in Rancho Cordova, California.


Sector: Healthcare
Industry: Medical Devices
Keywords: Life Sciences Biology Clinical Development Immunotherapy Clinics Bone Stem Cells Manufacturing Process Therapeutic Product Therapeutic Products Bone Marrow Chimeric Antigen Receptor Progenitor Cell Cord Blood Clinical Applications Liquid Nitrogen Umbilical Cord Cryopreservation

Is THMO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 14.18
52 Week Low 1.92
Average Volume 800,908
200-Day Moving Average 3.14
50-Day Moving Average 2.91
20-Day Moving Average 2.63
10-Day Moving Average 2.59
Average True Range 0.22
ADX 10.61
+DI 19.49
-DI 19.23
Chandelier Exit (Long, 3 ATRs ) 2.35
Chandelier Exit (Short, 3 ATRs ) 3.01
Upper Bollinger Band 2.88
Lower Bollinger Band 2.39
Percent B (%b) 0.41
BandWidth 18.79
MACD Line -0.09
MACD Signal Line -0.08
MACD Histogram -0.0106
Fundamentals Value
Market Cap 20.19 Million
Num Shares 7.8 Million
EPS -3.29
Price-to-Earnings (P/E) Ratio -0.79
Price-to-Sales 1.39
Price-to-Book 6.47
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.01
Resistance 3 (R3) 2.98 2.82 2.94
Resistance 2 (R2) 2.82 2.71 2.83 2.92
Resistance 1 (R1) 2.70 2.64 2.76 2.73 2.89
Pivot Point 2.54 2.54 2.57 2.55 2.54
Support 1 (S1) 2.42 2.43 2.48 2.45 2.29
Support 2 (S2) 2.26 2.36 2.27 2.26
Support 3 (S3) 2.14 2.26 2.24
Support 4 (S4) 2.17